Efficacy of Physiologically Active nutrients in the Treatment of Asthenic Disorders in Patients with Chronic Diffuse Liver Diseases

Over the period after an exacerbation of chronic liver diseases, patients often retain common symptoms (weakness or fatigue, bad mood, sleep disorder, vegetative disorders — asthenic syndrome). In the context of prevention and treatment of these symptoms, such nutraceutical products as enriched food...

Full description

Saved in:
Bibliographic Details
Main Authors: M. V. Mayevskaya, M. A. Morozova, A. G. Beniashvili, V. D. Lunkov, V. T. Ivashkin
Format: Article
Language:Russian
Published: Gastro LLC 2019-09-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
Online Access:https://www.gastro-j.ru/jour/article/view/397
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860163113648128
author M. V. Mayevskaya
M. A. Morozova
A. G. Beniashvili
V. D. Lunkov
V. T. Ivashkin
author_facet M. V. Mayevskaya
M. A. Morozova
A. G. Beniashvili
V. D. Lunkov
V. T. Ivashkin
author_sort M. V. Mayevskaya
collection DOAJ
description Over the period after an exacerbation of chronic liver diseases, patients often retain common symptoms (weakness or fatigue, bad mood, sleep disorder, vegetative disorders — asthenic syndrome). In the context of prevention and treatment of these symptoms, such nutraceutical products as enriched foods in the form of tablets, sachets, etc, have been increasingly attracting research attention.Aim. To study the efficacy of the “Hepato Smart” nutraceutical product for the treatment of asthenic syndrome in outpatients suffering from chronic diffuse liver diseases with compensated function and functional disorders of the gallbladder over the period after exacerbation.Materials and methods. The study included 50 patients, with 41 of them having completed the program. The nutraceutical product (curcumin, piperine, tanshinone IIA, choline; standardized for curcumin and choline) was assigned 1 pill 3 times a day with meals for 4 weeks. To objectify common symptoms, we used a D-FIS questionnaire (Daily Fatigue Impact Scale), a 4DSQ Four-Dimensional Symptom Questionnaire for assessing distress, depression, anxiety and somatization, and a SF-36 questionnaire for assessing the quality of life.Results. Following 4 weeks of the “Hepato Smart” course, a statistically significant decrease in fatigue was noted by D-FIS scores (p = 0.003), as well as a decrease in the level of distress, depression, anxiety and somatization by 4DSQ scores (p = 0.005; p = 0.006; p = 0.003; p = 0.003, respectively). The quality of patients’ life according to the SF36 questionnaire also improved due to both physical and psychological components (p = 0.003). 16 patients continued taking the preparation for another 8 weeks to maintain the achieved result. As an additional effect, the disappearance of pain in the right hypochondrium was noted in those cases when patients presented this complaint at the time of inclusion in the observation program. The safety profile was good, 1/3 of the patients noted the appearance of heartburn, which was eliminated when taking the product with food.Conclusion. The “Hepato Smart” nutraceutical product improves the general condition of patients with chronic diffuse liver diseases and functional disorders of the gallbladder due to a significant reduction in fatigue and anxiety. It also improves the quality of patients’ life due to the physical and mental components of health.
format Article
id doaj-art-ddeb3729ddd44cd29588a0e3b2ffbb2a
institution Kabale University
issn 1382-4376
2658-6673
language Russian
publishDate 2019-09-01
publisher Gastro LLC
record_format Article
series Российский журнал гастроэнтерологии, гепатологии, колопроктологии
spelling doaj-art-ddeb3729ddd44cd29588a0e3b2ffbb2a2025-02-10T16:14:35ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732019-09-01294505910.22416/1382-4376-2019-29-4-50-59319Efficacy of Physiologically Active nutrients in the Treatment of Asthenic Disorders in Patients with Chronic Diffuse Liver DiseasesM. V. Mayevskaya0M. A. Morozova1A. G. Beniashvili2V. D. Lunkov3V. T. Ivashkin4I.M. Sechenov First Moscow State Medical University (Sechenov University)Mental Health Research CentreMental Health Research CentreI.M. Sechenov First Moscow State Medical University (Sechenov University)I.M. Sechenov First Moscow State Medical University (Sechenov University)Over the period after an exacerbation of chronic liver diseases, patients often retain common symptoms (weakness or fatigue, bad mood, sleep disorder, vegetative disorders — asthenic syndrome). In the context of prevention and treatment of these symptoms, such nutraceutical products as enriched foods in the form of tablets, sachets, etc, have been increasingly attracting research attention.Aim. To study the efficacy of the “Hepato Smart” nutraceutical product for the treatment of asthenic syndrome in outpatients suffering from chronic diffuse liver diseases with compensated function and functional disorders of the gallbladder over the period after exacerbation.Materials and methods. The study included 50 patients, with 41 of them having completed the program. The nutraceutical product (curcumin, piperine, tanshinone IIA, choline; standardized for curcumin and choline) was assigned 1 pill 3 times a day with meals for 4 weeks. To objectify common symptoms, we used a D-FIS questionnaire (Daily Fatigue Impact Scale), a 4DSQ Four-Dimensional Symptom Questionnaire for assessing distress, depression, anxiety and somatization, and a SF-36 questionnaire for assessing the quality of life.Results. Following 4 weeks of the “Hepato Smart” course, a statistically significant decrease in fatigue was noted by D-FIS scores (p = 0.003), as well as a decrease in the level of distress, depression, anxiety and somatization by 4DSQ scores (p = 0.005; p = 0.006; p = 0.003; p = 0.003, respectively). The quality of patients’ life according to the SF36 questionnaire also improved due to both physical and psychological components (p = 0.003). 16 patients continued taking the preparation for another 8 weeks to maintain the achieved result. As an additional effect, the disappearance of pain in the right hypochondrium was noted in those cases when patients presented this complaint at the time of inclusion in the observation program. The safety profile was good, 1/3 of the patients noted the appearance of heartburn, which was eliminated when taking the product with food.Conclusion. The “Hepato Smart” nutraceutical product improves the general condition of patients with chronic diffuse liver diseases and functional disorders of the gallbladder due to a significant reduction in fatigue and anxiety. It also improves the quality of patients’ life due to the physical and mental components of health.https://www.gastro-j.ru/jour/article/view/397chronic diffuse liver diseasesasthenic syndromequality of lifenutraceutical product
spellingShingle M. V. Mayevskaya
M. A. Morozova
A. G. Beniashvili
V. D. Lunkov
V. T. Ivashkin
Efficacy of Physiologically Active nutrients in the Treatment of Asthenic Disorders in Patients with Chronic Diffuse Liver Diseases
Российский журнал гастроэнтерологии, гепатологии, колопроктологии
chronic diffuse liver diseases
asthenic syndrome
quality of life
nutraceutical product
title Efficacy of Physiologically Active nutrients in the Treatment of Asthenic Disorders in Patients with Chronic Diffuse Liver Diseases
title_full Efficacy of Physiologically Active nutrients in the Treatment of Asthenic Disorders in Patients with Chronic Diffuse Liver Diseases
title_fullStr Efficacy of Physiologically Active nutrients in the Treatment of Asthenic Disorders in Patients with Chronic Diffuse Liver Diseases
title_full_unstemmed Efficacy of Physiologically Active nutrients in the Treatment of Asthenic Disorders in Patients with Chronic Diffuse Liver Diseases
title_short Efficacy of Physiologically Active nutrients in the Treatment of Asthenic Disorders in Patients with Chronic Diffuse Liver Diseases
title_sort efficacy of physiologically active nutrients in the treatment of asthenic disorders in patients with chronic diffuse liver diseases
topic chronic diffuse liver diseases
asthenic syndrome
quality of life
nutraceutical product
url https://www.gastro-j.ru/jour/article/view/397
work_keys_str_mv AT mvmayevskaya efficacyofphysiologicallyactivenutrientsinthetreatmentofasthenicdisordersinpatientswithchronicdiffuseliverdiseases
AT mamorozova efficacyofphysiologicallyactivenutrientsinthetreatmentofasthenicdisordersinpatientswithchronicdiffuseliverdiseases
AT agbeniashvili efficacyofphysiologicallyactivenutrientsinthetreatmentofasthenicdisordersinpatientswithchronicdiffuseliverdiseases
AT vdlunkov efficacyofphysiologicallyactivenutrientsinthetreatmentofasthenicdisordersinpatientswithchronicdiffuseliverdiseases
AT vtivashkin efficacyofphysiologicallyactivenutrientsinthetreatmentofasthenicdisordersinpatientswithchronicdiffuseliverdiseases